Leadership Team
Executive Leadership
JASWINDER KHERA
Chief Executive Officer
At WEP Clinical, Jaswinder oversees the growth and strategy of the business in the Americas. Jaswinder brings over 30 years of experience in the pharmaceutical Industry in senior sales and marketing positions with Sanofi, MSD and Astra. He also held senior management positions in operations and business development during his 10 years with Quintiles.
SHAHEEN LIMBADA
Chief Operating Officer
Shaheen is a seasoned executive in the CRO and pharmaceutical industry, with over 23 years of experience in drug development, clinical operations, innovation and strategy, pharmacovigilance and post trial access solutions. He has worked in large pharma and CROs settings including AstraZeneca, LEO Pharma, Veristat and Topstone Research. Shaheen is a visionary leader who combines scientific expertise, business acumen, and operational excellence to deliver outstanding results for WEP clients and stakeholders. He is passionate about advancing clinical research and improving patient outcomes through innovation, collaboration and patient access.
KARL CHALLENDER
Chief Financial Officer
Karl has over 25 years of experience in the pharmaceutical and clinical research industry and has previously worked with organisations including Worldwide Clinical Trials, Novartis and Alcon. Karl brings a wealth of functional experience covering Operations, Finance, Logistics, Project Management and Sales and has a passion for patient service and delivery excellence.
Management Leadership
LEE SUTTON
Executive VP, Commercial Operations
Lee has over 12 years of global commercial leadership experience in the pharmaceutical and clinical research industry. Prior to joining WEP Clinical, Lee spent 7 years in a global commercial leadership role at Thermo Fisher Scientific. At WEP, Lee is responsible driving the strategy & growth of WEP’s global business development and marketing groups. Lee is an experienced, results-oriented commercial leader who possess strong operational experience and knowledge across clinical development and asset launch. His pragmatic and innovative thinking coupled with his straightforward business approach drives value and exceptional service to our clients and patients across the globe.
JEN BANKS
SVP, Global Project Management
WYNDI PHILLIPS
VP, Project Management
Wyndi is responsible for overseeing and leading the WEP Clinical global Project Management team, ensuring strong customer service and timely delivery of medications to patients around the world through Expanded Access and Post-Approval Named Patient Programs. Previously, she successfully led global teams in the management of clinical drug supply as Executive Director of Clinical Supplies at PRA Health Sciences and as a Project Group Manager at Almac Clinical Services. Wyndi earned her Doctor of Pharmacy degree from Campbell University and completed a residency at Mercer University. She has worked as a clinical pharmacist in hospital, ambulatory care, and community settings.
SIMON CLAYTON
VP, Named Patient Programs and Market Access
At WEP Clinical, Simon is responsible for expanding our commercial portfolio and growing our partnerships with Biopharmaceutical companies. Simon has 20 years of international experience in the Pharmaceutical industry with senior roles in Marketing, Business Management and Business Development at AstraZeneca, Abbvie and Clinigen.
MATT COMSTOCK
VP, Global Data and Monitoring Solutions
Matt has over two decades of experience working in the pharmaceutical and CRO space. He worked previously in data management and finance at Quintiles for nearly 15 years and also has experience in research, strategic account management, sales and relationship development. As the VP of Data and Safety Services at WEP Clinical, Matt is responsible for overseeing Data Management, Pharmacovigilance and Registry trial activities in alignment with the overall WEP business strategy.
Dr. Atalah Haun, MD
VP, Global Medical Affairs
Dr. Haun is an experienced medical doctor, trained in internal medicine and emergency medicine, with 10+ years of clinical practice, working in the drug development and research industry. Among his previous experiences, he was the head of a global medical affairs department, acted as primary medical monitor in 30+ clinical trials, mainly in complex studies in a variety of therapeutic areas including oncology, rare diseases, and advanced therapies. He joined WEP Clinical bringing his expertise in applying knowledge and skills in epidemiology, internal medicine and different medical specialties in drug development, clinical trials, and drug safety.
Andrea Gorasia
VP, Global Human Resources
Andrea brings over 20 years of extensive experience in Global HR and Operations to WEP Clinical. She is highly skilled at developing and implementing strategies that promote organizational excellence, with a strong emphasis on employee engagement and satisfaction. In her role, Andrea is responsible for aligning HR practices with business objectives, ensuring that the organization’s global HR strategy, talent acquisition, development, and retention are effectively shaped and executed. Additionally, Andrea is dedicated to cultivating a strong organizational culture and values that support WEP Clinical’s mission, ensuring that the company’s ethos is reflected in every aspect of its operations.
ANTONY REYNOLDS
VP, Head of Wren Healthcare
Antony is a seasoned professional with over 20 years of experience in the biotechnology and pharmaceutical industry. He has held a variety of sales and management roles and, in 2018, he founded Wren Healthcare, a specialist nursing and clinical education company. At Wren Healthcare, Antony leads the company’s global services, leveraging his deep knowledge of Decentralized Clinical Trial (DCT) market. Under Antony’s leadership, Wren Healthcare has become a leading provider of DCT services, supporting clients across all study phases and a broad spectrum of therapeutic areas.
Leadership Change
JASWANT KHERA
Managing Director EU
After 15 years of co-founding and building the company with my brother Jaswinder, I have decided to step away from the day to day running of the business and spend more time with my young family. I will still be involved with the business at Board level and will play an active role to drive the strategic growth and future success of WEP. It has been an amazing and fulfilling journey and I extend my gratitude to everyone who has contributed to our success to this point. My brother Jaswinder Khera will now assume the position of company-wide CEO from 1st November 2024.